These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer. Yuan C; Burns MB; Subramanian S; Blekhman R mSystems; 2018; 3(3):. PubMed ID: 29795787 [TBL] [Abstract][Full Text] [Related]
4. miRNA-Microbiota Interaction in Gut Homeostasis and Colorectal Cancer. Dong J; Tai JW; Lu LF Trends Cancer; 2019 Nov; 5(11):666-669. PubMed ID: 31735285 [TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment. Liu Y; Lau HC; Cheng WY; Yu J Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737 [TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer. Avuthu N; Guda C Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention. Pandey M; Bhattacharyya J Epigenomics; 2024 Mar; 16(6):403-418. PubMed ID: 38410915 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer and gut microbiota studies in China. Wang Z; Dan W; Zhang N; Fang J; Yang Y Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657 [TBL] [Abstract][Full Text] [Related]
9. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Xing J; Liao Y; Zhang H; Zhang W; Zhang Z; Zhang J; Wang D; Tang D Front Cell Infect Microbiol; 2022; 12():804689. PubMed ID: 35493741 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota in colorectal cancer development and therapy. Wong CC; Yu J Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888 [TBL] [Abstract][Full Text] [Related]
11. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer. Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675 [TBL] [Abstract][Full Text] [Related]
12. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions. Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748 [TBL] [Abstract][Full Text] [Related]
13. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers. Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961 [TBL] [Abstract][Full Text] [Related]
14. Role of gut microbiota in epigenetic regulation of colorectal Cancer. Zhao Y; Wang C; Goel A Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Faecal Microbiota and Small ncRNAs in Autism: Detection of miRNAs and piRNAs with Possible Implications in Host-Gut Microbiota Cross-Talk. Chiappori F; Cupaioli FA; Consiglio A; Di Nanni N; Mosca E; Licciulli VF; Mezzelani A Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405953 [TBL] [Abstract][Full Text] [Related]
16. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer. John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411 [TBL] [Abstract][Full Text] [Related]
17. The importance of interaction between MicroRNAs and gut microbiota in several pathways. Behrouzi A; Ashrafian F; Mazaheri H; Lari A; Nouri M; Riazi Rad F; Hoseini Tavassol Z; Siadat SD Microb Pathog; 2020 Jul; 144():104200. PubMed ID: 32289465 [TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer. Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866 [TBL] [Abstract][Full Text] [Related]
19. The role of gut microbiota in the development of colorectal cancer: a review. Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091 [TBL] [Abstract][Full Text] [Related]
20. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers. Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]